Urogenital tuberculosis
MONDO:0006002A general term for mycobacterium infections of any part of the urogenital system in either the male or the female.
Also known as: genitourinary system tuberculosis
14 clinical trials for this condition and its sub-types, 0 tagged with Urogenital tuberculosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urogenital tuberculosis
-
Tuberculous salpingitis 0 trials · 7 incl. sub-types
1 sub-type
- Meningeal tuberculosis 7 trials
-
Male genital tuberculosis 0 trials
1 sub-type
- Tuberculous epididymitis 0 trials
-
Primary genito-urinary tuberculosis 0 trials
-
Renal tuberculosis 0 trials
-
Tuberculous oophoritis 0 trials
-
Ureter tuberculosis 0 trials
-
Urinary bladder tuberculosis 0 trials
-
New hope for brain infection: experimental combo tackles tuberculous meningitis
Disease control Recruiting nowThis study tests a new combination of medicines (BPaLMZ) against the standard treatment for tuberculous meningitis, a serious brain infection. About 240 adults, including those living with HIV, will take part. The goal is to see if the new combo helps more people survive and reco…
Phase 2 • Sponsor: David Boulware • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a drug cocktail slash deaths from TB of the brain?
Disease control Recruiting nowThis Phase III trial in sub-Saharan Africa tests whether giving higher doses of rifampicin plus linezolid, along with aspirin, can reduce deaths from tuberculous meningitis (TBM) in both HIV-positive and HIV-negative people. About 768 adolescents and adults will receive either th…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common antibiotic slash deaths from brain TB?
Disease control Recruiting nowThis phase 2 trial tests whether adding the antibiotic doxycycline to standard treatment can reduce deaths and severe brain damage in adults with tuberculosis of the brain or its lining. About 200 participants will receive either doxycycline or a placebo for 8 weeks, alongside us…
Phase 2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a 6-Month drug cocktail beat 9 months for brain TB?
Disease control Recruiting nowThis study compares a 6-month treatment using high doses of four antibiotics against the standard 9-month therapy for tuberculous meningitis, a serious brain infection. About 330 adults and teens without HIV will take part. The goal is to see if the shorter regimen is as safe and…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could an arthritis drug save lives from a deadly brain infection?
Disease control Recruiting nowThis phase 2 trial tests whether adding adalimumab (an arthritis drug) to standard tuberculosis meningitis treatment can reduce deaths in HIV-positive adults. About 130 participants in Brazil, Mozambique, and Zambia will receive adalimumab injections every two weeks for 10 weeks …
Phase 2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Blood test could revolutionize TB treatment monitoring
Knowledge-focused Recruiting nowThis study explores whether measuring tiny DNA fragments from the TB bacteria in the blood can help doctors monitor how well treatment is working. Researchers will enroll 140 adults with newly diagnosed TB in Thailand, taking blood samples over time to see if the DNA levels drop …
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC